Maravai LifeSciences Reports Fourth Quarter and Full Year 2021 Financial Results and Updates 2022 Financial Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Maravai LifeSciences Reports Fourth Quarter and Full Year 2021 Financial Results and Updates 2022 Financial Guidance

Maravai LifeScience Holdings Inc. (MRVI) PT Lowered to $45 at Stifel

February 24, 2022 7:14 AM EST

Stifel analyst Daniel Arias lowered the price target on Maravai LifeScience Holdings Inc. (NASDAQ: MRVI) to $45.00 (from $56.00) while maintaining a Buy rating.

The analyst commented, "MRVI posted a solid top- and bottom-line beat driven by strength in CleanCap. Along with earnings, management provided... More

Maravai LifeSciences (MRVI) Tops Q4 EPS by 7c; Guides Higher

February 23, 2022 4:57 PM EST

Maravai LifeSciences (NASDAQ: MRVI) reported Q4 EPS of $0.45, $0.07 better than the analyst estimate of $0.38. Revenue for the quarter came in at $228.4 million versus the consensus estimate of $208.09 million.

GUIDANCE:

Maravai LifeSciences sees FY2022 EPS of $1.70-$1.84, versus the consensus of $1.54.... More